Switching Language

Please note that your current login session is only valid on the English site (letpub.com). You will not be signed in on other language versions of the site. If you wish to place an order, please return to the English site.

    Research Creative   My Account   Submit My Manuscript
Letpub, Scientific Editing Services, Manuscript Editing Service

Scientific Journal Selector


  
  
-

EXPERT OPINION ON INVESTIGATIONAL DRUGS


👁  21293 Views

 8 Reviews  

 Open Access      SCIE      Official Website     Submission Website
 

*Average Peer Review
Slow, 6-12 Week(s)
*Competitiveness
Ordinary
CiteScore
8.3
CiteScore Rank
Subject Area Rank Percentile
Category: Medicine
Subcategory: Pharmacology (medical)		 35 / 275
Category: Medicine
Subcategory: Pharmacology		 58 / 321
Link to PubMed Central (PMC)
https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1354-3784%5BISSN%5D

Indexing (SCI collection)
Science Citation Index Expanded (SCIE)
Scopus (CiteScore)

Country/Area of Publication
ENGLAND
Publication Frequency
Monthly
Publisher
Taylor and Francis Ltd.

ISSN
1354-3784
E-ISSN
1744-7658
Year Publication Started
1994

Self-citation (2024-2025)
2.40%
Annual Article Volume
99
Gold OA Percentage
4.63%

Open Access Info
APC APC Waiver Other Charges
N/A N/A N/A
Journal Aim & Scope
Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.

The Editors welcome:

Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies
Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.

Web of Science Quartiles
WOS Quartile: Q1

Quartiles By JIFCollectionQuartileRankPercentage
Category: PHARMACOLOGY & PHARMACYSCIEQ179/352
Quartiles By JCICollectionQuartileRankPercentage
Category: PHARMACOLOGY & PHARMACYSCIEQ289/353
*Crowdsourced data
  • Journals In The Same Subject Area
  • CiteScore Trends
  • Self Citation Trends
  • Annual Article Volume Trends
  • Journal Title h-index CiteScore
    DRUG RESISTANCE UPDATES10023.20
    TRENDS IN PHARMACOLOGICAL SCIENCES20125.70
    ADVANCED DRUG DELIVERY REVIEWS27836.00
    PHARMACOLOGICAL REVIEWS21034.00
    PHARMACOLOGY & THERAPEUTICS18026.20
    MEDICINAL RESEARCH REVIEWS11929.50
    PHARMACOLOGICAL RESEARCH11818.60
    PHYTOMEDICINE10511.60
    DRUG DELIVERY5216.40
    BRITISH JOURNAL OF PHARMACOLOGY19014.40
  • EXPERT OPINION ON INVESTIGATIONAL DRUGS EXPERT OPINION ON INVESTIGATIONAL DRUGS
    Predict CiteScore Trend：
    Steady Increase No Change Gradual Decline　 Refresh
 
    👁  21293 Views
    ☰  Reviews        
 
 
 

Select your rating and start your review of EXPERT OPINION ON INVESTIGATIONAL DRUGS

 

    Journals In The Same Field
    CA-A CANCER JOURNAL FOR CLINICIANS
    CiteScore: 1154.20
    NATURE REVIEWS DRUG DISCOVERY
    CiteScore: 181.80
    MMWR Recommendations and Reports
    CiteScore: 129.90
    Nature Reviews Clinical Oncology
    CiteScore: 114.50
    Nature Reviews Disease Primers
    CiteScore: 113.30
    NATURE REVIEWS CANCER
    CiteScore: 103.80
    NEW ENGLAND JOURNAL OF MEDICINE
    CiteScore: 96.40
    LANCET
    CiteScore: 87.60
    NATURE REVIEWS IMMUNOLOGY
    CiteScore: 84.70
    NATURE MEDICINE
    CiteScore: 82.40



    © 2010-2026  ACCDON LLC 400 5th Ave, Suite 530, Waltham, MA 02451, USA
    Privacy • Terms of Servic